Management and Prevention of Mucositis Supportive Care


Kepivance Reduces Toxicity of High-dose Therapy for Multiple Myeloma (March 24, 2010)

Among patients undergoing high-dose therapy and autologous stem cell transplantation for multiple myeloma, a three-day short course of Kepivance® (palifermin) reduces the toxicity of treatment. These... Continue Reading

Oral Spray Reduces Mouth Sores (July 21, 2009)

Among patients treated with radiation therapy for head and neck cancer, mouth sores (oral mucositis) were reduced by use of an oral spray containing epidermal growth factor (EGF). These results were published... Continue Reading

Update on the Management of Mucositis (November 5, 2007)

Update on the Management of Mucositis: A Report from the 2007 MASCC/ISOO International Symposium Introduction The fact that mucositis remains an important toxicity of cancer therapy was reflected in the... Continue Reading

Supportive Care Issues in Head and Neck Cancer: A Report from ASCO 2007 (October 12, 2007)

Supportive Care Issues in Head and Neck Cancer: A Report from ASCO 2007 Introduction With the use of combined modality therapy, clinical outcomes for locally advanced head and neck cancer (HNC) have improved... Continue Reading

Kepivance® May Decrease Oral Mucositis Following High-dose Chemotherapy for Hematologic Cancers (January 10, 2007)

Kepivance® May Decrease Oral Mucositis Following High-dose Chemotherapy for Hematologic Cancers Several studies presented at the 2006 meeting of the American society of Hematology in December suggest... Continue Reading

Kepivance® Reduces Mucositis After Allogeneic Stem Cell Transplantation (November 2, 2006)

Kepivance® Reduces Mucositis After Allogeneic Stem Cell Transplantation According to an article recently published in the journal Blood, Kepivance® (palifermin, keritinocyte growth factor), given before... Continue Reading

Daily Low-power Laser Therapy May Prevent Oral Mucositis in Stem Cell Transplant Patients (October 25, 2006)

Daily Low-power Laser Therapy May Prevent Oral Mucositis in Stem Cell Transplant Patients According to an article recently published in an early online version of the journal Blood, low-power laser therapy... Continue Reading

Ice Chips Prevent Mouth Sores Associated with High-Dose Chemotherapy (May 31, 2006)

Ice Chips Prevent Mouth Sores Associated with High-Dose Chemotherapy According to an article recently published in Bone Marrow Transplantation, sucking on ice chips may help to prevent oral mucositis associated... Continue Reading

Kepivance™ Reduces Frequency and Severity of Patient-Reported Mouth and Throat Soreness (April 13, 2006)

Kepivance™ Reduces Frequency and Severity of Patient-Reported Mouth and Throat Soreness Among patients undergoing stem-cell transplantation for leukemia, lymphoma, or multiple myeloma, treatment with... Continue Reading

Kepivance™ Significantly Reduces Medical Costs in Autologous Stem Cell Transplantation (December 29, 2004)

Kepivance™ Significantly Reduces Medical Costs in Autologous Stem Cell Transplantation According to results recently presented at the 46th annual meeting of the American Society of Hematology (ASH),... Continue Reading

FDA Approves Kepivance™ for Treatment of Mucositis (December 16, 2004)

FDA Approves Kepivance™ for Treatment of Mucositis The United States Food and Drug Administration (FDA) has approved Kepivance™ (palifermin), the first and only agent approved for the treatment of... Continue Reading

Ethyol® Decreases Side Effects Caused by Chemotherapy and Radiation in Inoperable Non-Small Cell Lung Cancer (May 7, 2004)

Ethyol® Decreases Side Effects Caused by Chemotherapy and Radiation in Inoperable Non-Small Cell Lung Cancer According to a recent article published in the International Journal of Radiation Oncology,... Continue Reading

Palifermin Improves Quality of Life in Patients Undergoing Stem Cell Transplantation (December 17, 2003)

Palifermin Improves Quality of Life in Patients Undergoing Stem Cell Transplantation According to results recently presented at the 2003 American Society of Hematology meeting, the agent Palifermin... Continue Reading

Mucositis Associated with Clinical Complications and Medical Cost (October 6, 2003)

Mucositis Associated with Clinical Complications and Medical Cost According to a recent article published in the journal Cancer, chemotherapy-induced mucositis is associated with additional clinical... Continue Reading

Palifermin (Rhu-KGF) Reduces Severity and Duration of Oral Mucositis (July 21, 2003)

Palifermin (Rhu-KGF) Reduces Severity and Duration of Oral Mucositis According to results presented at the 2003 annual meeting of the American Society of Clinical Oncology, palifermin, or recombinant human... Continue Reading

Aesgen-14 Reduces Mucositis in Patients Receiving Chemotherapy (February 7, 2003)

Aesgen-14 Reduces Mucositis in Patients Receiving Chemotherapy Aesgen-14 (AES-14) has recently been granted “fast track” status from the Food and Drug Administration (FDA) for the prevention... Continue Reading

Further Evidence that rHu-KGF Reduces Mucositis in Stem Cell Transplant Patients (January 31, 2003)

Further Evidence that rHu-KGF Reduces Mucositis in Stem Cell Transplant Patients According to recent results from a clinical trial, the use of recombinant human keratinocyte growth factor, or rHu-KGF,... Continue Reading

KGF Reduces Oral Mucositis in Patients Undergoing Autologous Stem Cell Transplants (February 25, 2002)

KGF Reduces Oral Mucositis in Patients Undergoing Autologous Stem Cell Transplants According to results reported at the 37 th Annual Meeting of the American Society of Clinical Oncology ,... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS